10x Genomics Statistics

Total Valuation

10x Genomics has a market cap or net worth of GBP 1.05 billion. The enterprise value is 799.45 million.

Market Cap	1.05B
Enterprise Value	799.45M

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	111.09M
Shares Outstanding	n/a
Shares Change (YoY)	+2.66%
Shares Change (QoQ)	+0.83%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	109.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.18
PB Ratio	1.93
P/TBV Ratio	1.98
P/FCF Ratio	30.02
P/OCF Ratio	24.00
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.58
EV / Sales	1.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	22.77

Financial Position

The company has a current ratio of 5.37, with a Debt / Equity ratio of 0.11.

Current Ratio	5.37
Quick Ratio	4.44
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	1.77
Interest Coverage	-60,528.88

Financial Efficiency

Return on equity (ROE) is -22.03% and return on invested capital (ROIC) is -14.20%.

Return on Equity (ROE)	-22.03%
Return on Assets (ROA)	-12.43%
Return on Invested Capital (ROIC)	-14.20%
Return on Capital Employed (ROCE)	-22.83%
Revenue Per Employee	370,201
Profits Per Employee	-93,066
Employee Count	1,306
Asset Turnover	0.68
Inventory Turnover	2.50

Taxes

In the past 12 months, 10x Genomics has paid 2.81 million in taxes.

Income Tax	2.81M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.12%
50-Day Moving Average	9.16
200-Day Moving Average	13.46
Relative Strength Index (RSI)	61.11
Average Volume (20 Days)	3,881

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.51

Income Statement

In the last 12 months, 10x Genomics had revenue of GBP 483.48 million and -121.54 million in losses. Loss per share was -1.00.

Revenue	483.48M
Gross Profit	330.50M
Operating Income	-140.55M
Pretax Income	-118.73M
Net Income	-121.54M
EBITDA	-113.69M
EBIT	-140.55M
Loss Per Share	-1.00

Full Income Statement

Balance Sheet

The company has 330.42 million in cash and 61.98 million in debt, giving a net cash position of 268.44 million.

Cash & Cash Equivalents	330.42M
Total Debt	61.98M
Net Cash	268.44M
Net Cash Per Share	n/a
Equity (Book Value)	547.13M
Book Value Per Share	4.44
Working Capital	365.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 43.92 million and capital expenditures -8.80 million, giving a free cash flow of 35.11 million.

Operating Cash Flow	43.92M
Capital Expenditures	-8.80M
Free Cash Flow	35.11M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 68.36%, with operating and profit margins of -29.07% and -25.14%.

Gross Margin	68.36%
Operating Margin	-29.07%
Pretax Margin	-24.56%
Profit Margin	-25.14%
EBITDA Margin	-23.51%
EBIT Margin	-29.07%
FCF Margin	7.26%

Dividends & Yields

10x Genomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.66%
Shareholder Yield	n/a
Earnings Yield	-11.53%
FCF Yield	3.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

10x Genomics has an Altman Z-Score of 5.27 and a Piotroski F-Score of 5.

Altman Z-Score	5.27
Piotroski F-Score	5